SCHEMBL4848854

SCHEMBL4848854

CC(C)(C)OC(=O)NCCC[C@H](CNC(=O)C[C@H](CCCN(Cc1ccccc1)C(=O)O)NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.46
ATM Q13315 1/20 0.43
SIRT5 Q9NXA8 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MMP1 P03956 1/20 0.42
MMP3 P08254 1/20 0.42
MMP9 P14780 1/20 0.42
CTSK P43235 3/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 1/20 0.41
KLK7 P49862 1/20 0.40
KLK5 Q9Y337 1/20 0.40
SIGMAR1 Q99720 1/20 0.39
CTSS P25774 2/20 0.39
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
PAX8 Q06710 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1023321 1.00 SYK (0.46) SYKATMSIRT5MEN1KMT2A
SCHEMBL4847719 0.91 SYK (0.47) SYKATMSIRT5MEN1KMT2A
SCHEMBL4847703 0.91 SYK (0.47) SYKATMSIRT5MEN1KMT2A
SCHEMBL1021128 0.90 SIRT5 (0.45) SYKATMSIRT5MEN1KMT2A
SCHEMBL4852088 0.89 SYK (0.48) SYKATMMEN1KMT2AMMP1
SCHEMBL1024156 0.89 SYK (0.48) SYKATMMEN1KMT2AMMP1
SCHEMBL1023983 0.88 SYK (0.42) SYKATMSIRT5MEN1KMT2A
SCHEMBL5066754 0.86 SYK (0.45) SYKATMSIRT5MEN1KMT2A
SCHEMBL1022335 0.86 SYK (0.53) SYKSIRT5MEN1KMT2AMMP1
SCHEMBL4853602 0.85 SYK (0.47) SYKATMSIRT5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446102-B2 Antibacterial amide macrocycles IV AICURIS GMBH & CO. KG (DE) 2008-11-04 US disclosed
US-20080076745-A1 ANTIBACTERIAL AMIDE MACROCYCLES IV AICURIS GMBH & CO. KG (DE) 2008-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076745-A1 ANTIBACTERIAL AMIDE MACROCYCLES IV NOD2, AAAS, AADAC SYK 3060/4885ATM 2832/4885SIRT5 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.